|
| 35916666 | The contemporary management of cancers of the sinonasal tract in adults. | CA Cancer J Clin | 2023 |
| 37568644 | Proton Bragg Peak FLASH Enables Organ Sparing and Ultra-High Dose-Rate Delivery: Proof of Principle in Recurrent Head and Neck Cancer. | Cancers (Basel) | 2023 |
| 35801573 | Outcomes for Organ Preservation with Chemoradiation Therapy for T4 Larynx and Hypopharynx Cancer. | Laryngoscope | 2023 |
| 37392723 | Managing cisplatin-ineligible patients with resected, high-risk, locally advanced squamous cell carcinoma of the head and neck: Is there a standard of care? | Cancer Treat Rev | 2023 |
| 37318798 | Osteoradionecrosis and Proton Therapy-Reply. | JAMA Otolaryngol Head Neck Surg | 2023 |
| 37147912 | Automated tracking of morphologic changes in weekly magnetic resonance imaging during head and neck radiotherapy. | J Appl Clin Med Phys | 2023 |
| 37079317 | Proton Therapy and Incidence and Predisposing Factors of Osteoradionecrosis-On Pulling One's Punches-Reply. | JAMA Otolaryngol Head Neck Surg | 2023 |
| 37174039 | Artificial Intelligence in CT and MR Imaging for Oncological Applications. | Cancers (Basel) | 2023 |
| 37439286 | Concurrent carboplatin and paclitaxel definitive radiation therapy for locally advanced head and neck cancer. | Head Neck | 2023 |
| 37169010 | Dosimetric Comparison of Intensity-Modulated Radiation Therapy (IMRT) and Intensity-Modulated Proton Therapy (IMPT) for a Novel Oral Tongue Avoidance Concept in Low-Risk Squamous Cell Carcinoma of the Oral Tongue. | Int J Part Ther | 2023 |
| 37435097 | Stem cell-like T cell depletion in the recurrent head and neck cancer immune microenvironment. | Oncoimmunology | 2023 |
| 37099979 | Post-operative PET/CT improves the detection of early recurrence of squamous cell carcinomas of the oral cavity. | Oral Oncol | 2023 |
| 37266942 | Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial. | JAMA Netw Open | 2023 |
| 36547968 | Osteoradionecrosis of the Jaw Following Proton Radiation Therapy for Patients With Head and Neck Cancer. | JAMA Otolaryngol Head Neck Surg | 2023 |
| 36689229 | Evaluation of Proton Therapy Reirradiation for Patients With Recurrent Head and Neck Squamous Cell Carcinoma. | JAMA Netw Open | 2023 |
| 36681089 | Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial. | Lancet Oncol | 2023 |
| 36181317 | American Head and Neck Society position statement on the use of PD-1 inhibitors for treatment of advanced cutaneous squamous cell carcinoma. | Head Neck | 2023 |
| 36305841 | Consensuses, controversies, and future directions in treatment deintensification for human papillomavirus-associated oropharyngeal cancer. | CA Cancer J Clin | 2023 |
| 34756495 | Outcomes following head and neck cancer surgery among older adults as determined by an electronic geriatric assessment. | J Geriatr Oncol | 2022 |
| 35679031 | Association of Low and Intermediate Combined Positive Scores With Outcomes of Treatment With Pembrolizumab in Patients With Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma: Secondary Analysis of Keynote 048. | JAMA Oncol | 2022 |
| 35841916 | Regaud, Rare Skin Cancer, and Radiotherapy. | Int J Radiat Oncol Biol Phys | 2022 |
| 35802849 | Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis. | J Clin Oncol | 2022 |
| 35737363 | Comparison of Objective Measures of Trismus and Salivation With Patient-Reported Outcomes Following Treatment for Head and Neck Cancer. | JAMA Otolaryngol Head Neck Surg | 2022 |
| 35583688 | Well-Differentiated Thyroid Cancer: Who Should Get Postoperative Radiation? | Ann Surg Oncol | 2022 |
| 35544650 | Implementation Strategies to Increase Clinical Trial Enrollment in a Community-Academic Partnership and Impact on Hispanic Representation: An Interrupted Time Series Analysis. | JCO Oncol Pract | 2022 |
| 35647395 | Peer Review of Head and Neck Cancer Planning Target Volumes in Radiation Oncology. | Adv Radiat Oncol | 2022 |
| 35537940 | Primary chondrosarcomas of the larynx treated with proton radiotherapy: A single institutional experience. | Cancer Rep (Hoboken) | 2022 |
| 35690646 | Prognostic impact of extranodal extension (ENE) in surgically managed treatment-naive HPV-positive oropharyngeal squamous cell carcinoma with nodal metastasis. | Mod Pathol | 2022 |
| 35521657 | A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image-Guided Stereotactic Body Radiotherapy in the Treatment of Metastatic Anaplastic Thyroid Cancer. | Thyroid | 2022 |
| 36455583 | International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic. | Lancet Oncol | 2022 |
| 36483055 | Correlation of an Electronic Geriatric Assessment With Receipt of Adjuvant Radiation and Chemotherapy in Older Adults With Head and Neck Cancer. | Adv Radiat Oncol | 2022 |
| 36367724 | Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy. | JAMA Netw Open | 2022 |
| 35865372 | In Reply to Qureshi et al. | Adv Radiat Oncol | 2022 |
| 36060412 | Outcomes and Toxicities of Nonmedullary Thyroid Tumors Treated with Proton Beam Radiation Therapy. | Int J Part Ther | 2022 |
| 35892883 | Qualitative and Quantitative Performance of Magnetic Resonance Image Compilation (MAGiC) Method: An Exploratory Analysis for Head and Neck Imaging. | Cancers (Basel) | 2022 |
| 36264562 | Methodologic Concerns in Secondary Analysis of KEYNOTE-048-Reply. | JAMA Oncol | 2022 |
| 36152642 | What to Expect When You're Expecting: Managing Oral Cavity Cancer in the Setting of a Second Trimester Pregnancy. | Int J Radiat Oncol Biol Phys | 2022 |
| 34918497 | JUPITER-02 trial: advancing survival for recurrent metastatic nasopharyngeal carcinoma and next steps. | Cancer Commun (Lond) | 2022 |
| 35183910 | Influence of Treatment Package Time on outcomes in High-Risk Oral Cavity Carcinoma in patients receiving Adjuvant Radiation and Concurrent Systemic Therapy: A Multi-Institutional Oral Cavity Collaborative study. | Oral Oncol | 2022 |
| 34971660 | Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial. | Radiother Oncol | 2022 |
| 34874302 | Prospectively-validated deep learning model for segmenting swallowing and chewing structures in CT. | Phys Med Biol | 2022 |
| 35050342 | Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy. | JAMA Oncol | 2022 |
| 32726432 | Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy. | J Natl Cancer Inst | 2021 |
| 33794205 | Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial. | Lancet Oncol | 2021 |
| 33571626 | International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma. | Int J Radiat Oncol Biol Phys | 2021 |
| 33704627 | The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying-the head and neck cancer model. | Cancer Causes Control | 2021 |
| 33586179 | Any day, split halfway: Flexibility in scheduling high-dose cisplatin-A large retrospective review from a high-volume cancer center. | Int J Cancer | 2021 |
| 33526794 | Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors. | Nat Commun | 2021 |
| 33800762 | Nongaussian Intravoxel Incoherent Motion Diffusion Weighted and Fast Exchange Regime Dynamic Contrast-Enhanced-MRI of Nasopharyngeal Carcinoma: Preliminary Study for Predicting Locoregional Failure. | Cancers (Basel) | 2021 |
| 33606323 | Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy. | Head Neck | 2021 |